scholarly journals Aberrant gut microbiota composition at the onset of type 1 diabetes in young children

Diabetologia ◽  
2014 ◽  
Vol 57 (8) ◽  
pp. 1569-1577 ◽  
Author(s):  
Marcus C. de Goffau ◽  
Susana Fuentes ◽  
Bartholomeus van den Bogert ◽  
Hanna Honkanen ◽  
Willem M. de Vos ◽  
...  
2021 ◽  
Vol 46 ◽  
pp. S657
Author(s):  
D.C. Fonseca ◽  
I.M.G. da Rocha ◽  
L. Callado ◽  
D.P.D.S. Pinelli ◽  
B.D. Balmant ◽  
...  

2020 ◽  
Vol 7 ◽  
Author(s):  
Ottavia Giampaoli ◽  
Giorgia Conta ◽  
Riccardo Calvani ◽  
Alfredo Miccheli

The global toll of type 1 diabetes (T1D) has steadily increased over the last decades. It is now widely acknowledged that T1D pathophysiology is more complex than expected. Indeed, a multifaceted interplay between genetic, metabolic, inflammatory and environmental factors exists that leads to heterogeneous clinical manifestations across individuals. Children with non-secretor phenotype and those affected by T1D share low abundance of bifidobacteria, low content of short-chain fatty acids, intestinal phosphatase alkaline and a high incidence of inflammatory bowel diseases. In this context, host-gut microbiota dyad may represent a relevant contributor to T1D development and progression due to its crucial role in shaping host immunity and susceptibility to autoimmune conditions. The FUT2 gene is responsible for the composition and functional properties of glycans in mucosal tissues and bodily secretions, including human milk. FUT2 polymorphisms may profoundly influence gut microbiota composition and host susceptibility to viral infections and chronic inflammatory disease. In this minireview, the possible interplay between mothers' phenotype, host FUT2 genetic background and gut microbiota composition will be discussed in perspective of the T1D onset. The study of FUT2-gut microbiota interaction may add a new piece on the puzzling T1D etiology and unveil novel targets of intervention to contrast T1D development and progression. Dietary interventions, including the intake of α-(1, 2)-fucosyl oligosaccharides in formula milk and the use of specific prebiotics and probiotics, could be hypothesized.


2020 ◽  
Vol 52 (7S) ◽  
pp. 665-665
Author(s):  
Kazuo Oguri ◽  
Kosho Kasuga ◽  
Syunsuke Yamaji ◽  
Tamotsu Kitabayashi ◽  
Tomoaki Sakai ◽  
...  

2018 ◽  
Author(s):  
A Emile J Hendriks ◽  
Ross L Ewen ◽  
Yoke Sin Hoh ◽  
Nazia Bhatti ◽  
Rachel M Williams ◽  
...  

Author(s):  
Elena Aghajanova ◽  
Arthur Melkonyan ◽  
Nina Alchujyan ◽  
Bayburdyan Gayane ◽  
Margarita Hovhannisyan ◽  
...  

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 1368-P ◽  
Author(s):  
ROWEN L. SECKOLD ◽  
PETER HOWLEY ◽  
BRUCE R. KING ◽  
KIRSTINE BELL ◽  
CARMEL E. SMART

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 1278-P
Author(s):  
IMAN AL-GADI ◽  
RANDI STREISAND ◽  
MAUREEN MONAGHAN ◽  
CARRIE TULLY ◽  
MANUELA SINISTERRA ◽  
...  

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 1290-P
Author(s):  
GIUSEPPE D’ANNUNZIO ◽  
ROBERTO BIASSONI ◽  
MARGHERITA SQUILLARIO ◽  
ELISABETTA UGOLOTTI ◽  
ANNALISA BARLA ◽  
...  

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 890-P
Author(s):  
DANIEL DESALVO ◽  
LAUREN KANAPKA ◽  
COLLEEN BAUZA ◽  
CICILYN XIE ◽  
LINDA DIMEGLIO ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document